NPAT fell 39.9% as NZ lockdowns overwhelmed a 140bps gross-margin lift

Annolyse's historical baseline classifies both PBT growth (4-period mean +27.3%) and NPAT growth (mean +27.2%) as unprecedented lows; PBT margin at 9.9% and NPAT margin at 7.0% are also unprecedented relative to the 12.5%–14.5% PBT-margin range seen across the comparable history window. Gross margin actually expanded 140bps to 57.9%, so the earnings drop reflects operating deleverage on lost revenue rather than price or mix erosion.

Segment splits make the driver explicit: Glassons Australia grew revenue 5.1% to NZ$71.9m with segment result up to NZ$10.7m, while Glassons New Zealand fell 13.6% (result NZ$3.7m, from NZ$5.8m) and Hallenstein Brothers fell 12.4% (result NZ$2.3m, from NZ$3.7m). Operating cash flow dropped 23.9% to NZ$21.2m, and the interim dividend was set at 18 cents per share.

• Gross margin rose 140bps, yet PBT margin landed at 9.9% versus a 13.4% historical mean. That gap is fixed-cost deleverage on the New Zealand and Hallenstein Brothers stores, not a structural margin reset, but it shows how thin the operating buffer is when ~13% of NZ-side revenue is removed. Investors should read this as a demand-side, not a cost-side, problem.

• The dividend payout is stretched well above the historical band. At 90.1% of NPAT, the payout sits 23.6 points above the 3-period historical mean of 66.5% and above the 61.7%–69.0% range. FCF pre-lease of NZ$18.2m still covers the declared dividend (payout 78.6% of FCF pre-lease), so the dividend is funded, but the NPAT-coverage gap signals the board is holding the dividend flat through the cycle rather than rebasing it.

• Cash generation weakened to an unprecedented low in absolute terms. Pre-lease FCF of NZ$18.2m sits NZ$16.1m below the NZ$34.3m historical mean and below the prior NZ$27.1m–NZ$40.9m range, even with a NZ$1.7m working-capital release helping the period. Lower earnings, not working-capital absorption, drove the shortfall.

Annualising current revenue gives NZ$341.3m, roughly 3% below FY21's NZ$350.8m, but the historical first-half share of FY21 was 51.9% of revenue and 59.6% of NPAT, so the second half is structurally lighter on profit. That shape means an FY22 NPAT comparable to FY21's NZ$33.3m would require the second half to outperform its usual seasonal profile, which the release does not commit to and the lockdown-driven 1H weakness does not obviously set up.

The gross-margin lift is genuine and was achieved despite revenue pressure, which supports the read that the business is not discounting through the downturn. Working capital provided a NZ$1.7m release (lower edge of the historical range, where prior periods averaged builds of NZ$4.3m), so cash conversion was modestly assisted but not abnormally so; inventory days at 23.9 sit above the 18.6–23.2 historical band, which is a balance-sheet item to monitor rather than a current cash drag.

The FCF/NPAT conversion of 152.9% looks flattering, but it reflects compressed NPAT as much as cash quality — absolute pre-lease FCF still fell roughly 30% versus the NZ$25.9m prior comparable. ROE at 28.0% remains within the historical range and ahead of the lowest historical reading, indicating the franchise has not structurally impaired even after a heavy earnings hit.

This briefing cannot assess post-period trading momentum, the specific lockdown-day impact on lost sales, or the company's working-capital intent for 2H without further disclosure.